Spago Nanomedical Ab

spago nanomedical is a swedish biotechnology company developing nanomaterials for cancer diagnostics and treatment. the company´s two main projects, spagopix and tumorad, are both based on the same proprietary nanomaterial. spagopix is a gadolinium-free contrast agent for magnetic resonance imaging (mri) with exceptionally high signal strength. by selectively accumulating in tumor tissue via passive tumor targeting, spagopix meets a well recognized need for significantly improved soft tissue tumor imaging. tumorad is a nanoprticle loaded with radionuclides being developed to target soft tissue tumors for radiopharmaceutical treatment. the design of tumorad enables it to selectively accumulate in tumor tissue and there deliver a controlled radiation dose.